Neumora Therapeutics Inc. has set terms for its initial public offering, as the Massachusetts-based biopharmaceutical company focused on treating brain...
Neumora Therapeutics Inc.
has set terms for its initial public offering, as the Massachusetts-based biopharmaceutical company focused on treating brain diseases looks to raise up to $264.8 billion. The company is offering 14.71 million shares in the IPO, which is expected to price between $16 and $18 a share. With about 151.95 million shares outstanding after the IPO, the company could be valued at up to $2.74 billion. The stock is expected to list on the Nasdaq under the ticker symbol “NMRA.” J.P.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
4 Huge Analyst Calls: Block Slashed on 'Lack of Catalysts'; Chewy Bumped to BuyStocks Analysis by Investing.com (Garrett Cook) covering: Block Inc, Chewy Inc, Cloudflare Inc, Surf Air Mobility Inc. Read Investing.com (Garrett Cook)'s latest article on Investing.com
Leer más »
Avengers Inc. #1 Preview: The Avengers' New Dress Code: NoirGot a murder mystery to solve and a celebrity hero to exploit? Avengers Inc. 1 is coming to bring you 'Avenging' with a fedora flip.
Leer más »
PodcastOne IPO Collides With Viral Takedown Video From Comedian Theo VonSpinoff of LiveOne falls nearly 50% one day after Von goes public with Kast Media allegations
Leer más »
Car-sharing service Turo restarts IPO plans for fallAfter a delay, Turo car-sharing business appears to be planning on going public this fall. It was valued in 2019 at a little over $1 billion.
Leer más »
Apple event, Arm Holdings IPO, UAW deadline, 9/11 anniversary top week aheadEarnings and economic data will begin on the 22nd anniversary of 9/11, with the largest IPO of 2023 expected midweek and UAW deadline for Ford, GM and Stellantis this week.
Leer más »
| Instacart to Target Much-Diminished Valuation Range of Under $10 Billion in IPOThe grocery-delivery company aims for $8.6 billion to $9.3 billion, down from $39 billion in 2021.
Leer más »